[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

March 2021 | 836 pages | ID: AA48B7A27889EN
Global Markets Direct

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development, 2021, provides an overview of the Acute Respiratory Distress Syndrome (Respiratory) pipeline landscape.

Acute respiratory distress syndrome (ARDS) occurs when fluid fills up the air sacs in lungs. This leads to low oxygen levels in the blood. Common causes of ARDS include sepsis, inhalation of harmful substances, severe pneumonia and head or chest injury. Signs and symptoms of ARDS include severe shortness of breath, labored and unusually rapid breathing, low blood pressure and confusion and extreme tiredness.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Respiratory Distress Syndrome - Drugs in Development, 2021, provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 19, 46, 27, 5, 64, 17 and 3 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 1, 2, 1, 1, 1 and 1 molecules, respectively.

Acute Respiratory Distress Syndrome (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Acute Respiratory Distress Syndrome (Respiratory).
  • The pipeline guide reviews pipeline therapeutics for Acute Respiratory Distress Syndrome (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Acute Respiratory Distress Syndrome (Respiratory) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Acute Respiratory Distress Syndrome (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Acute Respiratory Distress Syndrome (Respiratory)
REASONS TO BUY
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Acute Respiratory Distress Syndrome (Respiratory).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Acute Respiratory Distress Syndrome (Respiratory) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Introduction
Acute Respiratory Distress Syndrome - Overview
Acute Respiratory Distress Syndrome - Therapeutics Development
Acute Respiratory Distress Syndrome - Therapeutics Assessment
Acute Respiratory Distress Syndrome - Companies Involved in Therapeutics Development
Acute Respiratory Distress Syndrome - Drug Profiles
Acute Respiratory Distress Syndrome - Dormant Projects
Acute Respiratory Distress Syndrome - Discontinued Products
Acute Respiratory Distress Syndrome - Product Development Milestones
Appendix

LIST OF TABLES

Number of Products under Development for Acute Respiratory Distress Syndrome, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Companies, 2021 (Contd..2)
Number of Products under Development by Companies, 2021 (Contd..3)
Number of Products under Development by Companies, 2021 (Contd..4)
Number of Products under Development by Companies, 2021 (Contd..5)
Number of Products under Development by Companies, 2021 (Contd..6)
Number of Products under Development by Companies, 2021 (Contd..7)
Number of Products under Development by Companies, 2021 (Contd..8)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Products under Development by Companies, 2021 (Contd..6)
Products under Development by Companies, 2021 (Contd..7)
Products under Development by Companies, 2021 (Contd..8)
Products under Development by Companies, 2021 (Contd..9)
Products under Development by Companies, 2021 (Contd..10)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Target, 2021 (Contd..2)
Number of Products by Stage and Target, 2021 (Contd..3)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021 (Contd..2)
Number of Products by Stage and Mechanism of Action, 2021 (Contd..3)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Acute Respiratory Distress Syndrome - Pipeline by 9 Meters Biopharma Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by A6 Pharmaceuticals LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Acticor Biotech SAS, 2021
Acute Respiratory Distress Syndrome - Pipeline by Aerpio Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Akebia Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Akttyva Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Alexion Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Algernon Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Allero Therapeutics BV, 2021
Acute Respiratory Distress Syndrome - Pipeline by Ampio Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Amyndas Pharmaceuticals LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by APEIRON Biologics AG, 2021
Acute Respiratory Distress Syndrome - Pipeline by Apeptico Forschung und Entwicklung GmbH, 2021
Acute Respiratory Distress Syndrome - Pipeline by Aptahem AB, 2021
Acute Respiratory Distress Syndrome - Pipeline by Aqualung Therapeutics Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by Arch Biopartners Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Argenx SE, 2021
Acute Respiratory Distress Syndrome - Pipeline by Asalyxa Bio Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by AstraZeneca Plc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Athersys Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Avalon GloboCare Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by AVEM HealthCare LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Aviceda Therapeutics, 2021
Acute Respiratory Distress Syndrome - Pipeline by AVM Biotechnology LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Ayma Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Ayuvis Research Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bayer AG, 2021
Acute Respiratory Distress Syndrome - Pipeline by Baylx Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bharat Serums And Vaccines Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by BioCardia Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Biocon Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by BioLineRx Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by BioMarck Pharmaceuticals Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Biopharma Plasma LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Biophytis SA, 2021
Acute Respiratory Distress Syndrome - Pipeline by BioStem Technologies Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Biotest AG, 2021
Acute Respiratory Distress Syndrome - Pipeline by Biovista Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by BioXcellerator Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bioxytran Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Boehringer Ingelheim International GmbH, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bonac Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bone Therapeutics SA, 2021
Acute Respiratory Distress Syndrome - Pipeline by Bonus BioGroup Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by BrainStorm Cell Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cadila Pharmaceuticals Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by CalciMedica Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cartesian Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by CarthroniX Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Ceapro Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cellenkos Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cellresearch Corp Pte Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cellular Biomedicine Group Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Celularity Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cerecor Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Chiesi Farmaceutici SpA, 2021
Acute Respiratory Distress Syndrome - Pipeline by Citius Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by CohBar Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Curacle Co Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cynata Therapeutics Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Cytopeutics Pte Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Dianomi Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Diffusion Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Dimerix Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Direct Biologics LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Edesa Biotech Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Educell doo, 2021
Acute Respiratory Distress Syndrome - Pipeline by Emergent BioSolutions Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Emtora Biosciences, 2021
Acute Respiratory Distress Syndrome - Pipeline by Enzychem Lifesciences Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by EOM Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Eunoia Biotech LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by EUSA Pharma (UK) Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Evgen Pharma Plc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Exvastat Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by F. Hoffmann-La Roche Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by F4 Pharma GmbH, 2021
Acute Respiratory Distress Syndrome - Pipeline by Faron Pharmaceuticals Oy, 2021
Acute Respiratory Distress Syndrome - Pipeline by FibroGenesis LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Foresee Pharmaceuticals Co Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Fujifilm Holdings Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by GB Sciences Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by GEn1E Lifesciences Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Grifols SA, 2021
Acute Respiratory Distress Syndrome - Pipeline by Hemarina SA, 2021
Acute Respiratory Distress Syndrome - Pipeline by Histocell SL, 2021
Acute Respiratory Distress Syndrome - Pipeline by Human Life CORD Japan Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Humanetics Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by Iltoo Pharma, 2021
Acute Respiratory Distress Syndrome - Pipeline by ImmunityBio Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by IMMvention Therapeutix Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Implicit Bioscience Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Imstem Biotechnology Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by In2cure AB, 2021
Acute Respiratory Distress Syndrome - Pipeline by Incannex Healthcare Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Insmed Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by InVixa Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by IsletOne AB, 2021
Acute Respiratory Distress Syndrome - Pipeline by Jazz Pharmaceuticals Plc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Khondrion BV, 2021
Acute Respiratory Distress Syndrome - Pipeline by Kubota Vision Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Kyorin Pharmaceutical Co Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Lamellar Biomedical Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Lattice Biologics Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by LEAF4Life LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Liminal BioSciences Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Longeveron Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by LTT Bio-Pharma Co Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by MannKind Corp, 2021
Acute Respiratory Distress Syndrome - Pipeline by Matrix Biomed Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Medsenic SAS, 2021
Acute Respiratory Distress Syndrome - Pipeline by Meridigen Biotech Co Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Mesoblast Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Nano Biotherapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Neutrolis Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Northern Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Noxopharm Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by NS Pharma Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Omega Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Omnispirant Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Orbsen Therapeutics Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Orgenesis Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Orion Biotechnology Canada Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Orpheris Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Oryzon Genomics SA, 2021
Acute Respiratory Distress Syndrome - Pipeline by Pantherna Therapeutics GmbH, 2021
Acute Respiratory Distress Syndrome - Pipeline by Parnia Stem Cell Knowledge-Based Co, 2021
Acute Respiratory Distress Syndrome - Pipeline by Personalized Stem Cells Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by PharmAbcine Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Pharming Group NV, 2021
Acute Respiratory Distress Syndrome - Pipeline by Pliant Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Pluristem Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Predictive Biotech Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by R-Pharm, 2021
Acute Respiratory Distress Syndrome - Pipeline by RedHill Biopharma Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Relief Therapeutics Holding AG, 2021
Acute Respiratory Distress Syndrome - Pipeline by Restore Therapeutics LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Reven Pharmaceuticals Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Revolo Biotherapeutics Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by RION Health Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Roivant Sciences Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by Sage Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Santhera Pharmaceuticals Holding AG, 2021
Acute Respiratory Distress Syndrome - Pipeline by Savara Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Sentien Biotechnologies Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by SFA Therapeutics LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Shanghai Henlius Biotech Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by SMSbiotech Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by SolAeroMed Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Stemedica Cell Technologies Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Stempeutics Research Pvt Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by STERO Biotechs Ltd, 2021
Acute Respiratory Distress Syndrome - Pipeline by SynAct Pharma AB, 2021
Acute Respiratory Distress Syndrome - Pipeline by Thetis Pharmaceuticals LLC, 2021
Acute Respiratory Distress Syndrome - Pipeline by Trevena Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Validus Cellular Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Vasomune Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Veru Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Windtree Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Xfibra Inc, 2021
Acute Respiratory Distress Syndrome - Pipeline by Xintela AB, 2021
Acute Respiratory Distress Syndrome - Pipeline by ZyVersa Therapeutics Inc, 2021
Acute Respiratory Distress Syndrome - Dormant Projects, 2021
Acute Respiratory Distress Syndrome - Dormant Projects, 2021 (Contd..1)
Acute Respiratory Distress Syndrome - Dormant Projects, 2021 (Contd..2)
Acute Respiratory Distress Syndrome - Discontinued Products, 2021

LIST OF FIGURES

Number of Products under Development for Acute Respiratory Distress Syndrome, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021


More Publications